# A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

Study · id `cardio:ct-nct05496361` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05496361](<https://clinicaltrials.gov/study/NCT05496361>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05496361

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 238 participants.

## Technical summary

Registry record NCT05496361. Randomized; single masking; primary purpose treatment. Start 2021-01-24 (actual); primary completion 2021-11-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 238 participants (enrolled count; ClinicalTrials.gov record NCT05496361, source copy `cardio:ctgov-nct05496361-2022-08-11`, retrieved 2026-10-26)
- Started: 2021-01-24 (actual) (ClinicalTrials.gov record NCT05496361, source copy `cardio:ctgov-nct05496361-2022-08-11`, retrieved 2026-10-26)
- Primary completion: 2021-11-24 (actual) (ClinicalTrials.gov record NCT05496361, source copy `cardio:ctgov-nct05496361-2022-08-11`, retrieved 2026-10-26)
- Completion: 2022-07-20 (actual) (ClinicalTrials.gov record NCT05496361, source copy `cardio:ctgov-nct05496361-2022-08-11`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05496361, source copy `cardio:ctgov-nct05496361-2022-08-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05496361-2022-08-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
- Condition: AIS
- Condition: Acute Ischemic Stroke
- Condition: Large Vessel Occlusion
- Condition: Thrombectomy
- Intervention (Device): Tianyi Revascularization Device
- Intervention (Device): Solitaire FR Revascularization Device
- Lead sponsor: Suzhou Zenith Vascular SciTech Limited
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Suzhou Zenith Vascular SciTech Limited (`cardio:org-suzhou-zenith-vascular-scitech-limited`)

## Provenance

Content hash: 65b65cb97a14dbcf649696f6b162225116e465a6438fbeed561a067649d274db
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
